Tianjin Chase Sun Stock Soars 7.43%, Hits Intraday High of CNY 3.94

Tianjin Chase Sun Pharmaceutical Co., Ltd. has experienced a significant uptick in its stock performance, gaining 7.43% on August 13, 2026. The stock reached an intraday high of CNY 3.94, marking a notable achievement amid a broader market context where the China Shanghai Composite index declined by 0.5% on the same day. Over the past week, Tianjin Chase Sun has shown a robust performance with a 12.24% increase, and its monthly performance stands at 11.9%. However, the company has faced challenges over the longer term, with a one-year performance of -11.74% and a three-year decline of 26.27%. Despite these setbacks, the stock has generated a year-to-date return of 6.82%, contrasting with the negative performance of the broader market. Key financial metrics indicate a market capitalization of CNY 9,142 million, with a price-to-earnings ratio of 116.00. The company also boasts a dividend yield of 0.29%. While the stock has shown volatility, its recent performance highlights a moment of recovery in a challenging environment.